These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25672778)

  • 21. Using insulin in type 2 diabetes: in need of a renaissance?
    Kerr D; Olateju T
    J Diabetes Sci Technol; 2011 Jul; 5(4):829-33. PubMed ID: 21880221
    [No Abstract]   [Full Text] [Related]  

  • 22. The Polish Diabetes Association (PTD) modified target haemoglobin A1c and blood pressure values in diabetic patients.
    Kos-Kudła B
    Endokrynol Pol; 2014; 65(3):155-7. PubMed ID: 25102564
    [No Abstract]   [Full Text] [Related]  

  • 23. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
    Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic inertia amongst general practitioners with interest in diabetes.
    Seidu S; Than T; Kar D; Lamba A; Brown P; Zafar A; Hussain R; Amjad A; Capehorn M; Martin E; Fernando K; McMoran J; Millar-Jones D; Kahn S; Campbell N; Brice R; Mohan R; Mistry M; Kanumilli N; St John J; Quigley R; Kenny C; Khunti K
    Prim Care Diabetes; 2018 Feb; 12(1):87-91. PubMed ID: 28993141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To What Target Hemoglobin A1c Level Would You Treat This Patient With Type 2 Diabetes?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Smetana GW; Nathan DM; Dugdale DC; Burns RB
    Ann Intern Med; 2019 Oct; 171(7):505-513. PubMed ID: 31569249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Criteria influencing the choice of starting insulin regimen in patients with type 2 diabetes in routine clinical practice: baseline data from the Algerian cohort of the A₁chieve study.
    Malek R; Arbouche Z; Bachaoui M; Zinai S; Dahaoui A; Senoussaoui S; Salah-Mansour A
    Diabetes Res Clin Pract; 2013 Aug; 101 Suppl 1():S45-9. PubMed ID: 23958572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [INERTIA study: Clinical inertia in non-insulinized patients on oral hypoglycemic treatment. A study in Spanish primary and specialty care settings].
    González-Clemente JM; Font B; Lahoz R; Llauradó G; Gambús G;
    Med Clin (Barc); 2014 Jun; 142(11):478-84. PubMed ID: 23622897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemoglobin A1c outcomes and health care resource use in type 2 diabetes mellitus patients treated with combination oral antidiabetic drugs through step therapy and loose-dose and fixed-dose combinations.
    Williams SA; Buysman EK; Hulbert EM; Bergeson JG; Zhang B; Graham J
    Manag Care; 2012 Jul; 21(7):40-8. PubMed ID: 22876522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An observational, multicentre study on different insulin glargine U100 titration algorithms used in patients with type 2 diabetes in daily medical practice in Adriatic countries: The ADRESA study.
    Krnić M; Marolt I; Skelin M; Grulović N; Rahelić D
    Diabetes Res Clin Pract; 2019 Apr; 150():144-149. PubMed ID: 30641166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
    Tasci I; Safer U; Naharci I; Sonmez A
    Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozin.
    Blonde L; Patel C; Bookhart B; Pfeifer M; Chen YW; Wu B
    Curr Med Res Opin; 2018 Jun; 34(6):1143-1152. PubMed ID: 29595326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin Monotherapy.
    Mahabaleshwarkar R; Gohs F; Mulder H; Wilkins N; DeSantis A; Anderson WE; Ejzykowicz F; Rajpathak S; Norton HJ
    Clin Ther; 2017 Aug; 39(8):1658-1670.e6. PubMed ID: 28689692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.
    Neumark AS; Brudin L; Neumark T
    Prim Care Diabetes; 2015 Aug; 9(4):253-60. PubMed ID: 25865853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Decision Support System for Diabetes Based on Ontology Reasoning and TOPSIS Analysis.
    Chen RC; Jiang HQ; Huang CY; Bau CT
    J Healthc Eng; 2017; 2017():4307508. PubMed ID: 29312655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in quality of diabetes care at the levels of patient, physician, and clinic.
    O'Connor PJ; Rush WA; Davidson G; Louis TA; Solberg LI; Crain L; Johnson PE; Whitebird RR
    Prev Chronic Dis; 2008 Jan; 5(1):A15. PubMed ID: 18082004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjustments to diabetes medications in response to increases in hemoglobin a1c: an epidemiologic study.
    Davis J; Chavez B; Juarez DT
    Ann Pharmacother; 2014 Jan; 48(1):41-7. PubMed ID: 24449495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between different hemoglobin A1c levels and clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus.
    Davis KL; Wei W; Meyers JL; Kilpatrick BS; Pandya N
    J Am Med Dir Assoc; 2014 Oct; 15(10):757-62. PubMed ID: 25106810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.
    Pantalone KM; Wells BJ; Chagin KM; Ejzykowicz F; Yu C; Milinovich A; Bauman JM; Kattan MW; Rajpathak S; Zimmerman RS
    Diabetes Care; 2016 Sep; 39(9):1527-34. PubMed ID: 27519447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early glycaemic control among patients with type 2 diabetes and initial glucose-lowering treatment: a 13-year population-based cohort study.
    Thomsen RW; Baggesen LM; Svensson E; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetes Obes Metab; 2015 Aug; 17(8):771-80. PubMed ID: 25929277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in HbA1c prescription for patients with diabetes in French general practice: an observational study prior to the implementation of a P4P programme.
    Chauvel N; Le Vaillant M; Pelletier-Fleury N
    Eur J Public Health; 2013 Feb; 23(1):61-6. PubMed ID: 22219502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.